In the context of Alzheimer’s disease, lentivirus vectors have been applied for RNA silencing to knock down BACE1 attenuated amyloid precursor protein (APP) cleavage and β-amyloid production, resulting in reduced neurodegeneration and behavioral deficits in an Alzheimer’s disease mouse model [53]. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.